Stock Price Prediction

RELL stock closed at $13.12, down 1.80%, but surged 7.47% in after-hours trading to $14.10 after announcing the sale of its healthcare segment and a 10-year supply agreement. This strategic move strengthens its focus on core segments like Green Energy Solutions, which saw 129% growth in Q2 FY2025. Bullish sentiment arises from its robust financials, no debt, and optimistic outlook for continued profitability.

RELL stock closed at $13.12, down 1.80%, but surged 7.47% in after-hours trading to $14.10 following the sale of its Healthcare segment to DirectMed Imaging. This move consolidates operations into its PMT segment, signaling a strategic shift but raises concerns about near-term revenue stability. Bears may view the stock as overbought post-announcement, with resistance near $14.50.

The market consensus for RELL's revenue in the upcoming quarter is projected to be approximately $60.77M USD.